Stockreport

Revance Reports Additional Positive Week 24 Efficacy Results from RT002 Injectable Phase 2 Cervical Dystonia Trial

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF - Poster on display today to be presented during late-breaking session on June 7, 2017, at 21st International Congress of Parkinson’s Disease and Movemen [Read more]